|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
73,830,000 |
Market
Cap: |
3.76(B) |
Last
Volume: |
392,807 |
Avg
Vol: |
691,819 |
52
Week Range: |
$43.07 - $67.51 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Electronics |
Level
III Sector: |
Semiconductor Equipment & Materials |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
|
NASDAQ COMPUTER |
|
S&P SMALLCAP 600 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 443 |
Guru Rank Value : 3.1 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Azenta provides life science sample exploration and management solutions. Co.'s segments are: Life Sciences Products, which provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables, and instruments; and Life Sciences Services, which provides sample management programs, cold chain solutions, informatics, as well as sample-based laboratory services, including sample storage, genomic sequencing, gene synthesis, laboratory processing services, laboratory analysis, biospecimen procurement services and other support services to scientific research and support drug development.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
12,975 |
Total Buy Value |
$0 |
$0 |
$0 |
$752,191 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
39,197 |
39,197 |
Total Sell Value |
$0 |
$0 |
$2,183,306 |
$2,183,306 |
Total People Sold |
0 |
0 |
2 |
2 |
Total Sell Transactions |
0 |
0 |
5 |
5 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Headley Martin S |
EVP & Chief Financial Officer |
|
2013-02-04 |
4 |
D |
$9.26 |
$65,190 |
D/D |
(7,040) |
506,741 |
|
- |
|
Montone William T. |
SVP, Human Resources |
|
2013-02-04 |
4 |
D |
$9.26 |
$23,391 |
D/D |
(2,526) |
181,880 |
|
- |
|
Schwartz Stephen S |
President, CEO |
|
2013-02-04 |
4 |
D |
$9.26 |
$64,996 |
D/D |
(7,019) |
765,462 |
|
- |
|
Joseph Jason |
VP, General Counsel, Secretary |
|
2013-01-31 |
4 |
A |
$7.79 |
$11,692 |
D/D |
1,500 |
109,500 |
|
- |
|
Haris Clinton M. |
SVP, Brooks Life Sciences |
|
2013-01-31 |
4 |
A |
$7.79 |
$11,692 |
D/D |
1,500 |
173,284 |
|
- |
|
Montone William T. |
SVP, Human Resources |
|
2013-01-25 |
4 |
AS |
$9.50 |
$26,600 |
D/D |
(2,800) |
184,406 |
|
- |
|
Montone William T. |
SVP, Human Resources |
|
2013-01-25 |
4 |
OE |
$7.75 |
$21,700 |
D/D |
2,800 |
187,206 |
|
- |
|
Haris Clinton M. |
SVP, Brooks Life Sciences |
|
2012-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
171,784 |
|
- |
|
Joseph Jason |
VP, General Counsel, Secretary |
|
2012-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
108,000 |
|
- |
|
Headley Martin S |
EVP & Chief Financial Officer |
|
2012-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
70,000 |
513,781 |
|
- |
|
Park Chong Sup |
Director |
|
2012-12-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
36,645 |
|
- |
|
Allen A Clinton |
Director |
|
2012-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,200 |
43,300 |
|
- |
|
Allen A Clinton |
Director |
|
2012-12-11 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,300 |
8,700 |
|
- |
|
Schwartz Stephen S |
President, CEO |
|
2012-12-02 |
4 |
D |
$7.71 |
$160,754 |
D/D |
(20,850) |
622,481 |
|
- |
|
Allen A Clinton |
Director |
|
2012-11-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
13,000 |
44,500 |
|
- |
|
Martin Joseph R |
Director |
|
2012-11-19 |
4 |
S |
$7.21 |
$35,931 |
D/D |
(4,983) |
38,784 |
|
- |
|
Steven A. Michaud |
SVP, Brooks Product Solutions |
|
2012-11-08 |
4 |
D |
$7.23 |
$11,460 |
D/D |
(1,585) |
221,215 |
|
- |
|
Mirchandani Kush |
SVP, Worldwide Sales |
|
2012-11-08 |
4 |
D |
$7.23 |
$10,498 |
D/D |
(1,452) |
80,666 |
|
- |
|
Mathews Timothy S |
Principal Accounting Officer |
|
2012-11-08 |
4 |
D |
$7.23 |
$4,960 |
D/D |
(686) |
56,660 |
|
- |
|
Headley Martin S |
EVP & Chief Financial Officer |
|
2012-11-08 |
4 |
D |
$7.23 |
$40,481 |
D/D |
(5,599) |
443,781 |
|
- |
|
Leitzke Thomas |
SVP, Global Operations |
|
2012-11-08 |
4 |
D |
$7.23 |
$13,368 |
D/D |
(1,849) |
103,484 |
|
- |
|
Haris Clinton M. |
SVP, Brooks Life Sciences |
|
2012-11-08 |
4 |
D |
$7.23 |
$13,260 |
D/D |
(1,834) |
136,784 |
|
- |
|
Mathews Timothy S |
Principal Accounting Officer |
|
2012-11-06 |
4 |
A |
$0.00 |
$0 |
D/D |
12,000 |
68,660 |
|
- |
|
Schwartz Stephen S |
President, CEO |
|
2012-11-06 |
4 |
D |
$7.80 |
$116,649 |
D/D |
(14,955) |
643,331 |
|
- |
|
Schwartz Stephen S |
President, CEO |
|
2012-11-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(7,350) |
658,286 |
|
- |
|
1055 Records found
|
|
Page 28 of 43 |
|
|